Beijing starts vaccinating key groups against COVID-19 XBB subvariants
Share - WeChat
BEIJING -- Beijing has started administering key groups with COVID vaccines targeting the XBB subvariants of Omicron, Beijing Center for Disease Prevention and Control said on Monday.
People aged 60 and above, or between 18 and 59 years but with serious underlying diseases, low immune function, or high risk of infection, are eligible to receive XBB vaccines at this stage if they have been infected with COVID-19 or received at least two doses of COVID-19 vaccines.
The COVID-19 Omicron XBB subvariants have developed into one of the dominant subvariants in the world, according to the World Health Organization. Therefore, vaccines containing the antibody of the XBB subvariants are recommended for better effect, the center said.
- International Congress of Basic Science wraps up in Beijing
- Shanghai Chongming Dongtan added to World Heritage List
- When Tunisian blogger meets Shanghai
- 5 killed, 14 injured in industrial park blast in China's Henan
- Two Chinese sites added to World Heritage List
- HK hopes to achieve more glory in Paris